Viewing Study NCT04433156


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-01 @ 10:01 AM
Study NCT ID: NCT04433156
Status: UNKNOWN
Last Update Posted: 2023-05-18
First Post: 2020-06-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module